Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Income from Continuing Operations (2021 - 2026)

HeartSciences (HSCS) has disclosed Income from Continuing Operations for 5 consecutive years, with 2352937.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations fell 11.9% year-over-year to 2352937.0, compared with a TTM value of 9062944.0 through Oct 2025, down 17.01%, and an annual FY2025 reading of 8853024.0, down 32.93% over the prior year.
  • Income from Continuing Operations was 2352937.0 for Q4 2025 at HeartSciences, down from 2057807.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 752051.0 in Q3 2021 and bottomed at 2550949.0 in Q1 2025.
  • Average Income from Continuing Operations over 5 years is 1742265.22, with a median of 1778045.5 recorded in 2022.
  • The sharpest move saw Income from Continuing Operations plummeted 109.25% in 2022, then increased 20.55% in 2023.
  • Year by year, Income from Continuing Operations stood at 1034770.0 in 2021, then crashed by 74.7% to 1807710.0 in 2022, then grew by 3.28% to 1748381.0 in 2023, then fell by 20.26% to 2102631.0 in 2024, then decreased by 11.9% to 2352937.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for HSCS at 2352937.0 in Q4 2025, 2057807.0 in Q3 2025, and 2101251.0 in Q2 2025.